Home » Attend

2nd Patient Empowerment World Congress 2026 Europe

““Part of Patient Centricity & Collaboration Series”

“Connecting Patients, Clinicians, Industry and Policymakers to Transform Healthcare Through Partnership, Innovation and Empowerment.”

Hilton London Kensington, London, United Kingdom

Wednesday 14th - Thursday 15th October 2026

FACILITATE LIVE is very pleased to welcome you to our upcoming 2nd PATIENT EMPOWERMENT World Congress 2026 Europe. The congress focuses on “Connecting Patients, Clinicians, Industry and Policymakers to Transform Healthcare Through Partnership, Innovation and Empowerment.

Patient empowerment refers to enabling individuals to gain the knowledge, skills, confidence, and authority to actively participate in decisions about their health and healthcare. Rather than being passive recipients of care, empowered patients become informed partners who collaborate with healthcare professionals to manage their conditions, make treatment decisions, and improve their overall well-being.

Traditionally, healthcare systems followed a paternalistic model in which clinicians made most decisions for patients. Today, however, there is growing recognition that patients who understand their health conditions and engage in their care are more likely to achieve better outcomes. Patient empowerment, therefore, shifts healthcare toward shared decision-making, transparency, and respect for patient preferences, values, and lived experiences. A fundamental aspect of patient empowerment is access to clear and reliable information. Patients need understandable guidance about their diagnoses, treatment options, potential risks, and expected outcomes. Health literacy plays a crucial role in enabling individuals to interpret this information and navigate complex healthcare systems. When patients are well informed, they can make better decisions and participate more confidently in discussions about their care.

Involving patients in treatment decisions and ensuring they understand their care plans significantly improves adherence to prescribed medications and therapies. By combining shared decision-making with comprehensive patient education, individuals can choose treatments that align with their needs and lifestyles. This collaborative approach leads to improved health outcomes, quicker recovery, reduced anxiety, and a greater likelihood that patients will adopt healthier lifestyles and actively monitor their conditions.

Patient empowerment is particularly important for people living with chronic diseases, where self management plays a key role. Empowered patients are more likely to monitor symptoms, manage medications effectively, and take preventive actions to maintain their health. Healthcare providers support this process through education, coaching, and digital tools that help patients track and manage their well-being.

When patients feel heard and respected, it strengthens their relationship with healthcare providers and encourages open communication and trust. This engagement is also essential for the pharmaceutical and life sciences industries. Patient insights help identify unmet needs, improve the design of clinical trials, and guide the development of therapies and support programs that better reflect real patient experiences. Patients who are actively involved in research are also more likely to participate in clinical studies and remain engaged throughout the process.

Patient empowerment also supports ethical principles by respecting patient autonomy and enabling individuals to make informed decisions about their health. By ensuring that all patients have access to information, resources, and support, empowerment can also help address health disparities and promote greater health equity.

The two-day Congress will bring together stakeholders across healthcare, pharmaceuticals, patient advocacy, research, and policy, as well as patients and caregivers themselves. It will explore the growing importance of patient empowerment and its implications for both patients and the life sciences industry, with the goal of fostering meaningful dialogue, collaboration, and more patient-centered healthcare systems.

We look forward to meeting you at the Congress!

GAIN LATEST INSIGHTS ON:

By the end of this two-day congress, participants will be able to:

  • Explain the principles of patient empowerment and patient-centred care and their impact on improving health outcomes, patient satisfaction, and healthcare system efficiency.
  • Apply strategies to improve health literacy and patient education, enabling patients to better understand their conditions, treatment options, and care pathways.
  • Integrate shared decision-making approaches into clinical and care practices to ensure treatment plans align with patient values, preferences, and lifestyles.
  • Identify effective methods to support patient self- management, particularly for individuals living with chronic diseases, through education, digital tools, and care coordination.
  • Assess how patient insights and lived experiences can inform healthcare service design, improving care pathways and overall patient experience.
  • Evaluate the role of patient advocacy groups and community organisations in advancing patient engagement, policy influence, and healthcare innovation.
  • Examine strategies for incorporating patient perspectives into clinical trial design and drug development, improving recruitment, retention, and research relevance.
  • Explore the use of real-world evidence and patient- reported outcomes to better understand treatment effectiveness and inform healthcare decision-making.
  • Analyse how digital health technologies—such as telehealth, wearables, and patient portals—can empower patients to manage their health and improve access to care.
  • Recognise opportunities for the pharmaceutical and life sciences industries to build meaningful partnerships with patients, enhancing trust, transparency, and collaboration.
  • Identify best practices for developing patient support programmes that improve medication adherence, disease management, and quality of life.
  • Assess approaches for addressing health inequalities and improving access to care, ensuring patient empowerment strategies are inclusive and equitable.
  • Develop cross-sector collaboration strategies among healthcare providers, industry, researchers, policymakers, and patient organisations to advance sustainable patient-centred healthcare systems. 

WHO SHOULD ATTEND?

This Congress is beneficial to pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology and healthcare companies.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Leaders in the area of:

  • Patients
  • Patient Engagement
  • Patient Services
  • Engagement Strategy
  • R&D Patient Engagement
  • Medical Affairs
  • Commercialisation
  • Marketing
  • Regulatory Affairs and Policy
  • Patient Support
  • RWE, and Data Management
  • Quality and Compliance
  • Clinical Development and Operations
  • Programme Management
  • Supply Chain Management
  • Patient Access
  • Clinical Research
  • Digital Accelerator
  • Patient Engagement & Portfolio Strategy
  • Patient Support
  • Strategy & Insights
  • Patient Experience
  • Global Patient Advocacy & Alliances
  • Government Policy and Advocacy
  • Digital Patient Experience Lead
  • Clinical Insights and Experience
  • Head of Strategy, Access Services
  • Site Collaborations and Patient Centricity

Delegate Tickets

Early Bird and Group Discounts Available Now!

Patients / Patient Group

Subject To Approval
Guest Pass
  • 2 - Day Full Access
  • Welcome Coffee & Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.

Non Profit / Acedemic

Verification Required
£499
  • 2 - Day Full Access
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities.

Standard Vendor Registration Rate

Vendors / Service / Solution Providers / Consultants / CRO's
£1999
  • 2 - Day Full Access
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities

Standard Registration Rate

Pharma / Biotech
£1299
  • 2 - Day Full Access
  • Welcome Coffee and Refreshments
  • All Day Refreshments
  • Lunches for the 2 Days
  • Full Access to Conference Documentation
  • Networking & Partnering Opportunities

Gold Sponsor

Scroll to Top